These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8989014)

  • 1. Differential effects of two intraventricularly injected alpha 2 agonists, ST-91 and dexmedetomidine, on electroencephalogram, feeding, and electromyogram.
    Dowlatshahi P; Yaksh TL
    Anesth Analg; 1997 Jan; 84(1):133-8. PubMed ID: 8989014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological evidence for different alpha 2-adrenergic receptor sites mediating analgesia and sedation in the rat.
    Buerkle H; Yaksh TL
    Br J Anaesth; 1998 Aug; 81(2):208-15. PubMed ID: 9813525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors.
    Powell SB; Palomo J; Carasso BS; Bakshi VP; Geyer MA
    Psychopharmacology (Berl); 2005 Jul; 180(3):491-500. PubMed ID: 15719216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intrathecally administered imiloxan and WB4101: possible role of alpha 2-adrenoceptor subtypes in the spinal cord.
    Takano Y; Takano M; Yaksh TL
    Eur J Pharmacol; 1992 Sep; 219(3):465-8. PubMed ID: 1358645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine.
    Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist.
    Takano Y; Yaksh TL
    J Pharmacol Exp Ther; 1991 Aug; 258(2):438-46. PubMed ID: 1678011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic spinal infusion of dexmedetomidine, ST-91 and clonidine: spinal alpha 2 adrenoceptor subtypes and intrinsic activity.
    Takano Y; Yaksh TL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):327-35. PubMed ID: 8093729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intrathecally administered dexmedetomidine, MPV-2426 and tizanidine on EMG in rats.
    Talke P; Xu M; Paloheimo M; Kalso E
    Acta Anaesthesiol Scand; 2003 Mar; 47(3):347-54. PubMed ID: 12648203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the I(1) imidazoline/alpha(2)-adrenergic receptor agonist moxonidine in comparison with clonidine in the formalin test in rats.
    Shannon HE; Lutz EA
    Pain; 2000 Mar; 85(1-2):161-7. PubMed ID: 10692615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression by spinal alpha-2 agonists of motor and autonomic responses evoked by low- and high-intensity thermal stimuli.
    Saeki S; Yaksh TL
    J Pharmacol Exp Ther; 1992 Feb; 260(2):795-802. PubMed ID: 1346645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic potency of alpha adrenergic agents after systemic administration in amphibians.
    Brenner GM; Klopp AJ; Deason LL; Stevens CW
    J Pharmacol Exp Ther; 1994 Aug; 270(2):540-5. PubMed ID: 7915313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of alpha 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats.
    Riekkinen P; Lammintausta R; Ekonsalo T; Sirviö J
    Eur J Pharmacol; 1993 Jul; 238(2-3):263-72. PubMed ID: 8104809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.
    Vayssettes-Courchay C; Bouysset F; Cordi AA; Laubie M; Verbeuren TJ
    Br J Pharmacol; 1996 Feb; 117(3):587-593. PubMed ID: 8821553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats.
    Takano Y; Yaksh TL
    J Pharmacol Exp Ther; 1992 May; 261(2):764-72. PubMed ID: 1349648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonic vocalization production of preweanling rats: effects of central and peripheral administration of alpha2-adrenoceptor agonists.
    Krall CM; Andicochea CT; McDougall SA
    Eur J Pharmacol; 2005 Jul; 517(3):200-7. PubMed ID: 15985263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 2-adrenoceptor-blocking properties of midaglizole (DG-5128) in rats.
    Hirohashi M; Tanaka M; Suzuki I; Akashi A
    Arch Int Pharmacodyn Ther; 1990; 306():75-86. PubMed ID: 1981668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 2-adrenoceptors mediate clonidine-induced sedation in the rat.
    Drew GM; Gower AJ; Marriott AS
    Br J Pharmacol; 1979 Sep; 67(1):133-41. PubMed ID: 40643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-2 adrenoceptor agonists decrease cyclic guanosine 3',5'-monophosphate in the mouse brain.
    Vulliemoz Y; Shen H; Virag L
    Anesthesiology; 1996 Sep; 85(3):544-50. PubMed ID: 8853084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.